Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10907647 | Experimental Hematology | 2005 | 12 Pages |
Abstract
KHYG-1 is a valuable model for the study of enhanced cytotoxicity by NK cells. In addition to the activation of NKp44, KHYG-1 may induce apoptosis of tumor cells by the newly described granzyme M/perforin pathway. Targeted modifications of effector molecules demonstrated in this model could generate NK cells with even greater killing ability that may be particularly attractive for clinical application. Moreover, our demonstration of greater cytotoxicity of KHYG-1 versus NK-92 cells, already in clinical trials, suggests a direct therapeutic role for KHYG-1.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Garnet Suck, Donald R. Branch, Mark J. Smyth, Richard G. Miller, Joanna Vergidis, Soad Fahim, Armand Keating,